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AbstrACt
Introduction The success of combination antiretroviral 
therapy has decreased the risk of perinatal HIV 
transmission and normalised pregnancy in women 
living with HIV (WLWH). Despite these advances, WLWH 
still face complex medical and psychosocial issues 
during pregnancy and postpartum, and there is a gap of 
knowledge on the experiences of becoming and being a 
mother living with HIV in today’s context. The overall aim 
of this study is to investigate psychosocial outcomes and 
experiences of WLWH in Scandinavia during pregnancy 
and early motherhood.
Methods and analysis This is a multicentre longitudinal 
convergent mixed methods study consisting of a 
quantitative survey study, a qualitative interview study 
and a mixed methods analysis. The survey study aims 
to examine psychosocial outcomes of WLWH across 
the pregnancy – postpartum trajectory. Participants are 
pregnant WLWH living in Scandinavia. Two control groups 
of HIV- negative pregnant women and non- pregnant 
WLWH are also included. Data is collected in the third 
trimester, 3 and 6 months postpartum using standardised 
questionnaires. Statistical analysis will assess changes 
over time and identify predictors of adverse outcomes. 
The interview study seeks to understand experiences of 
pregnancy and becoming a mother while living with HIV. 
Pregnant WLWH who are enrolled in the survey study will 
be asked to participate in individual interviews in the third 
trimester and 6 months postpartum. Data will be analysed 
using narrative analysis. The survey and interview results 
will be merged in a mixed methods analysis to assess 
confirmation, expansion or discordance between the data 
sets.
Ethics and dissemination Approval from the Danish 
Data Protection Agency (VD-2018–253), and the Finnish 
and Swedish Ethics Committees have been obtained 
(HUS/1330/2019 and Dnr: 2019–04451, respectively). 
Study results will be disseminated to patient organisations, 
through publications in peer- reviewed journals and at 
scientific conferences.
IntroduCtIon
The success of combination antiretroviral 
therapy (cART) has resulted in a relative 
normalisation of pregnancy and a dramatic 
decrease in perinatal HIV transmission.1–3 
Despite these advancements, women living 
with HIV (WLWH) still face complex medical 
and psychosocial issues during pregnancy, 
childbirth and postpartum.4 5 Although there 
has been increase in the annual number of 
HIV pregnancies in the last decade, both 
strengths and limitations of this study
 ► Use of a convergent mixed methods longitudinal de-
sign will provide descriptive information of psycho-
social outcomes in women living with HIV (WLWH) 
across the pregnancy – postpartum trajectory, in 
addition to an in- depth understanding of the experi-
ences of these women.
 ► This study will include pregnant WLWH in three 
Scandinavian countries (Denmark, Finland and 
Sweden), and follow them longitudinally.
 ► Two control groups are included in the study to 
assess differences in psychosocial health among 
pregnant WLWH, pregnant women not living with HIV 
and non- pregnant WLWH.
 ► It is a limitation that patients and public were not in-
volved in the development of the research question 
or the design of the study.
 ► The small sample size, due to low numbers of preg-
nant WLWH in Scandinavia, is also a study limitation.
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in Scandinavia and internationally,1 6 a gap exists in the 
research literature on the experiences of becoming and 
being a mother while living with HIV in today’s current 
context.
Women living with HIV in scandinavia
There are approximately 1400, 1000 and 2800 WLWH 
in Denmark, Finland and Sweden, respectively, of whom 
80% are of childbearing age.7–9 The majority of WLWH 
in Scandinavia are immigrants, mainly from sub- Saharan 
Africa, and HIV has mainly been transmitted by sexual 
contact.8 10 The healthcare system in the Nordic countries 
is tax- based and ensures universal access to both medical 
healthcare and many social support services.11 Hence, 
cART is provided free of charge and people living with 
HIV in Scandinavia are generally well treated with life 
expectancies approaching those of the general popula-
tion.8 9 12 National antenatal screening for all pregnant 
women has been implemented as an opt- out programme 
(eg, all women are screened unless they decline).13 The 
proportion of WLWH that are diagnosed during preg-
nancy range between 18% to 37%.8 10 Treatment with 
cART has been recommended to all pregnant WLWH 
in Scandinavia since the late 1990’s and most women 
have an undetectable viral load at the time of delivery, 
resulting in a decreased risk of perinatal transmission 
to <1%.1 8 10 14 Condomless sex without assistance from 
artificial reproductive technologies and vaginal delivery 
are recommended in well- treated WLWH.1–3 8 15 Newborn 
treatment with prophylactic antiretroviral medicine lasts 
for 4 weeks after birth.8 14 16 The annual number of chil-
dren born to WLWH in both Denmark and Finland has 
increased from 10 in the year 2000 to 45 in 2014, with no 
evidence of perinatal transmission of HIV if the mother 
has been well- treated with cART.1 8 10 In Sweden, approx-
imately 60 to 80 children are born to WLWH each year.17
HIV and pregnancy
Several studies have shown that WLWH have fertility 
desires similar to the desires of the general popula-
tion.18 19 Despite the normalisation of pregnancy in 
WLWH, becoming and being a mother with HIV is 
associated with unique pregnancy and postpartum 
considerations.5 In addition to the usual stresses of new 
motherhood, WLWH must also cope with stressors that 
include their own health, the unknown infectious states 
of their infants and attending to their infants’ unique 
needs such as the administration of prophylactic medi-
cations.5 In Scandinavia, national guidelines recommend 
not breastfeeding to WLWH as a small risk of perinatal 
transmission of HIV through the consumption of breast-
milk remains, even in the context of cART.8 14 16 Several 
studies have highlighted the complexity and uniqueness 
of this issue for WLWH.20 21 Breastfeeding generally is 
considered natural and important for the mother- child 
relationship. Not being able to breastfeed may go against 
what is considered ‘good mothering’”.22 Moreover, breast-
feeding may be the cultural norm for some immigrant 
women and formula feeding may be interpreted as a sign 
of HIV.23
Psychosocial and emotional well- being is essential to 
women during pregnancy to facilitate attachment to the 
newborn and to develop the capacity to parent effec-
tively.24 Stigma continues to be a significant concern for 
WLWH.25 26 Interactions with healthcare professionals can 
either contribute to the women’s feelings of normality or 
enhance their experience of being different. Stigmatised 
care throughout the pregnancy–postpartum trajectory 
(eg, the period from pregnancy to after birth) has been 
reported in the literature.4 26 27 HIV- related stigma experi-
enced during pregnancy may be associated with increased 
risk of depression, stress and social isolation.26 A high 
prevalence of depression in pregnant and postpartum 
WLWH is reported in several studies.28–30 Depression 
represents one of the most frequent distress conditions 
in the context of the transition to motherhood, and 
may be associated to a range of adverse behavioural and 
emotional outcomes for the child.31 The perception of 
being under surveillance due to increased medical moni-
toring during pregnancy may also affect the psychological 
well- being of these women.32
Thus, WLWH continue to contend with complex 
medical and psychosocial issues during pregnancy and 
early motherhood.5 33 Previous research in WLWH has 
concentrated on the physical health of the mother, 
prevention of perinatal transmission and the health of the 
unborn baby.34 35 While these foci are important, there 
remains a gap in knowledge about the impact of HIV on 
the psychosocial health and experiences of pregnant and 
postpartum WLWH. This study seeks to improve under-
standing of the maternal health challenges facing WLWH, 
such as stigma, perinatal depression and emotional well- 
being, so that goal- oriented interventions can be devel-
oped to improve the pregnancy and birth experience 
among WLWH.
objECtIVEs
The overall aim of this study is to investigate psychoso-
cial outcomes and experiences of WLWH in Scandinavia 
during pregnancy and early motherhood.
The specific objectives are:
Quantitative phase:
1. To examine psychosocial outcomes of women living 
with HIV across the pregnancy–postpartum trajectory.
2. To identify factors associated with adverse outcomes.
3. To assess differences in psychosocial outcomes be-
tween pregnant women living with HIV, non- pregnant 
women living with HIV and pregnant women not living 
with HIV.
Qualitative phase:
1. To elucidate the range of experiences of pregnancy 
and early motherhood while living with HIV among 
women in Scandinavia.
Integrated mixed methods analysis:
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Figure 1 Study diagram. MM, mixed methods; WLWH, women living with HIV.
1. To integrate the quantitative survey findings and qual-
itative interview findings with the intent of obtaining a 
more comprehensive understanding of the psychoso-
cial experiences and needs of WLWH across the preg-
nancy–postpartum trajectory.
Hypothesis
The hypothesis for the quantitative phase is that Scandi-
navian WLWH experience a high burden of psychosocial 
health challenges during pregnancy and early moth-
erhood compared with the control groups, such as an 
increased prevalence of depression, stigma and social 
isolation, and this may be associated with their social situ-
ation, maternal country of birth and perception of stigma.
study dEsIgn
This is a multicentre longitudinal mixed methods (MM) 
research study. MM research is defined as an approach to 
research in which both quantitative and qualitative data 
are collected, analysed and integrated, thereby drawing 
interpretations based on the combined strengths of both 
sets of data.36 Increasingly, MM methodologists empha-
sise the importance of integration, not just qualitative 
and quantitative studies being conducted concurrently.37 
The rational for using MM in this project lies in the need 
to gather different kind of data to answer the research 
objectives. Collecting both quantitative and qualitative 
data will enhance understanding not only of the psycho-
social health of WLWH during pregnancy and early 
motherhood, but also elucidate the nuances and details 
of the women’s experiences. Thus, using a MM approach 
will provide a more comprehensive understanding of 
the psychosocial and emotional care needs of WLWH in 
Scandinavia.
A convergent and longitudinal MM research design will 
be used. This is characterised by collecting and analysing 
quantitative and qualitative data separately but within the 
same study phase. The quantitative and qualitative results 
are then brought together through merging, with the 
aim of comparing the results.36 38 39 This project consists 
of two phases (see figure 1 and table 1). A quantitative 
phase with a prospective survey study using standardised 
self- report instruments and qualitative phase with a quali-
tative study using interviews. The use of a convergent MM 
design has a complementary aim as opposed to being part 
of a validation strategy.40 Thus, the results from the two 
phases will be merged in an integrated MM analysis to 
assess confirmation, expansion or discordance between 
the data sets.39
theoretical framework
The philosophical and epistemological assumption that 
forms this research is pragmatism, a view that frames 
the integration of quantitative and qualitative methods 
within a single study from a question driven philosophy. 
Hence, this study is driven by research questions rather 
than an a priori stance regarding superiority of research 
methods.36 41
MEtHods
Quantitative phase
Population
In Denmark, treatment and care of pregnant WLWH are 
centralised at eight specialised centres during pregnancy 
and four specialised centres for delivery, and all pregnant 
WLWH living in Denmark will be asked to participate if 
they meet the inclusion criteria. In Finland, a majority 
of WLWH deliver at Helsinki University Hospital,8 while 
Sahlgrenska University Hospital treats about five to seven 
pregnant WLWH yearly. Eligible women are identified 
and recruited consecutively by the medical staff during 
routine clinical appointments at these centres. No hono-
rarium is provided to participants. The inclusion criteria 
are: 18 years of age or older, pregnant, living with HIV, 
anticipated birth of a viable infant without life- threatening 
conditions or congenital anomalies, can speak and read 
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Danish, Finnish, Swedish or English and willing to partic-
ipate for the duration of the study. The estimated sample 
size is 80 WLWH. This is based on the number of children 
born to WLWH in the participating countries during the 
study period.
Control groups
Two control groups will be included in the quantitative 
survey study. Control group A consists of non- pregnant, 
women living with HIV, consecutively enrolled from the 
participating Departments of Infectious Diseases. The 
inclusion criteria are: between 18 and 45 years of age, 
living with HIV, not pregnant or planning to become 
pregnant, can speak and read Danish, Finnish, Swedish 
or English and willing to participate for the duration of 
the study
Control group B consists of pregnant women not living 
with HIV, consecutively enrolled at the Departments of 
Obstetrics at Copenhagen University Hospital, Hvidovre, 
Helsinki University Hospital or Sahlgrenska University 
Hospital. The inclusion criteria are: 18 years of age or 
older, pregnant, not living with HIV, anticipated birth 
of a viable infant without life- threatening conditions or 
congenital anomalies, no known chronic or psychiatric 
illness associated with increased surveillance or adverse 
pregnancy and birth outcome, can speak and read 
Danish, English, Swedish or Finnish and willing to partic-
ipate for the duration of the study.
A ratio of 1 case:2 controls is chosen to increase preci-
sion. Thus, the estimated sample size is 160 participants 
in each control group.
Data collection
Data will be collected using standardised questionnaires 
at three time points; in the third trimester, 3 and 6 months 
postpartum (T1, T2 and T3, respectively). Control group 
A will follow the same time frame, that is, baseline, 3 to 4 
months and 6 to 7 months. The questionnaire is available 
in English, Danish, Finnish and Swedish. Participants will 
answer the questionnaire themselves electronically in 
REDCap. Clinical data will be collected from the medical 
records and entered into the REDCap database.
Psychosocial outcomes
The HIV Stigma scale – short version will be used to measure 
overall perceived stigma, personalised stigma, disclosure 
concerns, negative self- image and concern of public atti-
tudes.42 43 The scale consists of 12 items. Responses are on 
a 4- point Likert scale ranging from ‘strongly disagree’ to 
‘strongly agree’. A sum score is calculated, with a higher 
score indicating higher rates of perceived stigma.42 43 The 
HIV Stigma scale has been shown to be a reliable and 
valid measure of HIV- related stigma, also in WLWH popu-
lations.44 The scale has been translated and validated in 
a Swedish context.45 To utilise the sociocultural adapta-
tions, the Swedish version will be translated into Danish 
and Finnish, and pilot tested prior to initiation of this 
proposed study. The HIV Stigma scale is not distributed 
to control group B.
The Edinburgh Postnatal Depression Scale (EPDS) will be 
used to assess symptoms of perinatal depression.46 The 
scale has 10- items with responses on a 4- point Likert 
scale ranging from 0 (absence of depressive moods) to 3 
(worst mood). A total score ranging from 0 to 30 is calcu-
lated, and a cut- off point of ≤12 indicates an increased 
likelihood of clinical depression.46 The EPDS has been 
translated into Danish, Finnish and Swedish, has a well- 
documented validity and reliability and has been shown 
to be sensitive to changes over time.46 47 The scale does 
not mention the words pregnancy, child, birth or infant 
and has also been validated in a non- pregnant popula-
tion.48 49
Perceived stress will be measured using the Perceived 
Stress Scale – 10 item (PSS-10), a self- administered scale that 
was developed to measure ‘the degree to which situations 
in one’s life are appraised as stressful’ during the past 
month.50 Responses are on a Likert- type 5- point format 
that ranges from 0 (never) to 4 (very often). The range 
for scores is 0 to 40 with higher scores reflecting greater 
perceptions of stress. The PSS-10 has been translated and 
validated in Danish Finnish and Swedish.51–53
Perceived social isolation will be assessed using the 
third version of the University of California, Los Angeles 
(UCLA) loneliness scale.54 The short version of the scale 
including three items will be used.55 Responses are on 
a 3- point Likert scale ranging from 1 (hardly ever) to 3 
(often). Responses are summed into a total score, where 
higher scores indicate a greater degree of loneliness.54 55 
The UCLA loneliness scale is the most widely used self- 
report scale measuring loneliness and has acceptable 
validity and reliability.54 56 The scale has been translated 
and validated in a Danish and Finnish context, respec-
tively.57 58 The scale will be translated into Swedish using a 
translation – back- translation procedure.59
The Multidimensional scale of Perceived Social Support 
(MSPSS), a 12–item scale, is used to assess social 
support.60 61 The scale consists of three subscales; Family, 
Friends and Significant Others. Each item is answered 
from 1 (strongly disagree) to 5 (strongly agree). The total 
scores for each subscale range from 4 to 20, with higher 
scores suggesting a greater level of perceived social 
support. The MSPSS is a frequently used measure of 
social support in somatic illness, and good reliability and 
validity has been reported, also in a Danish context.62 63 
The scale has also been translated and used in a Finnish 
and Swedish setting.64 65
The PACIFY questionnaire will be used to assess infant 
feeding perceptions and experiences among WLWH. 
The questionnaire was developed for a UK study inves-
tigating infant feeding among WLWH and contains 20 
questions (personal communication w/Hermione Lyall). 
A modified version asking general questions about infant 
feeding will be used for control group B. The question-
naire will be translated into Danish, Finnish and Swedish, 
and is pilot tested prior to initiation of the study.
 on N
ovem
ber 14, 2019 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2018-027761 on 15 O
ctober 2019. D
ow
nloaded from
 
6 Moseholm E, et al. BMJ Open 2019;9:e027761. doi:10.1136/bmjopen-2018-027761
Open access 
Clinical data
The following data will be collected from the patient 
records: maternal country of birth, maternal age at 
delivery, family situation, education, parity, mode of 
delivery, HIV medication, CD4 cell count, viral load, cART 
adherence, comorbidity, non- HIV medication, smoking, 
alcohol and drug use.
Statistical analysis
Descriptive statistics of demographic characteristics in 
the third trimester (T1) will be computed. The results 
of the different psychosocial outcomes (stigma, depres-
sion, stress, social isolation and social support) will be 
summarised at each time point (T1, T2, T3) to describe 
changes in mean scores of the different instruments over 
time and between groups. Only participants with data 
at all three time point will be included in this analysis. 
Bivariate correlations will be examined to determine rela-
tionships between the different study outcomes at all time 
points. Multiple regression analysis will be completed to 
explore the relationship between HIV- related stigma and 
multiple independent variables at all three time points 
and in the different exposure groups. A similar model will 
be used to explore the relationship between symptoms 
of depression and multiple independent variables. The 
co- variables included in the models will be chosen a priori 
based on the results from the bivariate analysis and clin-
ical relevance. The site of enrolment will also be included 
in the model to account for variability between countries 
and sites. Analyses will be performed using Stata 13 soft-
ware in collaboration with an experienced statistician. All 
reported p values are two- sided using a significance level 
of 0.05.
Qualitative phase
This descriptive qualitative phase consists of individual 
interviews connected (that is, involving the same partic-
ipants) with the survey study through sampling. The 
interviews will be conducted in the third trimester of 
pregnancy and 6 months after birth.
Participants
All WLWH enrolled in survey study will be asked to partic-
ipate in the qualitative phase and participants will be 
consecutively sampled until reaching data saturation (ie, 
the point when no substantially new information emerges 
from the interviews).36 66 Hence, WLWH will be recruited 
for both the survey and the interviews within the same 
time period. We anticipate that approximately 25 to 35 
women will be sampled during pregnancy and at least 
15 (accounting for attrition) in the second interview 6 
months after birth.
Interviews
A study investigator will conduct individual interviews 
using a hybrid, narrative/semi- structured format.67 68 
The opening question will be: ‘Can you tell us what your 
pregnancy/birth/mothering experiences have been like 
for you as a woman living with HIV?’ This will allow each 
woman to share her story. Probes will be used as clari-
fying and elaborating questions throughout the inter-
views, thus expanding the stories the women share within 
the larger narrative.67 Hence, initially participants will be 
asked to give a full narrative of their experiences. This 
is followed by a series of semi- structured questions and 
probes, to elaborate on themes not brought up by the 
woman herself (see online supplementary file 1). This 
ensures that the specified themes explored in the survey, 
for example, stigma, stress, depression, social isolation 
and social support, are also elaborated in the interviews. 
Thus, the same concepts are explored in both phases of 
the study, while still making room for new insights and 
perspectives. The interviews will be audio- recorded and 
will be conducted at the participant’s home or at the rele-
vant hospital, whichever the woman prefers.
Analysis
The audio- recorded interviews will be transcribed 
verbatim using a transcription protocol and analysed using 
narrative thematic analysis as described by Riessman.69 70 
A thematic approach will be used where themes are iden-
tified as ‘told’ by the participant.70 Emphasis is on the 
content of the text, ‘what’ is said more than ‘how’ it is 
said.69 The analysis involves several steps: (1) The inter-
views are read several times to obtain a sense of the whole. 
(2) Emergent themes and patterns across the transcripts 
are identified, while paying close attention to the unique-
ness of the whole story that was told. (3) The themes are 
compared for similarities and differences across partici-
pants and their narratives. Finally, the themes are brought 
together to create a coherent core story or a series of core 
stories.69 The first author (EM) will complete the initial 
analysis, which is then discussed with the research team 
to critically reflect on and review interpretations of the 
findings, and to make sure that the findings are based on 
the participating women’s narrative. NVivo 12 software, 
QSR International Pty Ltd, will be used in the analysis.
Mixed methods integration and analysis
Integration in MM research is defined as an intentional 
process by which the researcher brings qualitative and 
quantitative data together in one study.36 In this study, the 
quantitative survey data and qualitative interview data will 
be brought together for analysis through merging. The 
preliminary overarching themes across the quantitative 
and qualitative data are stigma, depression, stress, social 
isolation and social support. As an iterative approach is 
applied to the analysis, these themes may change based on 
the quantitative and qualitative results. Using joint display 
analysis, the survey and interview results will be merged by 
matching in a side- by- side comparison to assess confirma-
tion, expansion or discordance between the data sets.36 39 
Confirmation occurs if the findings from one type of data 
reinforce the results from the other. Expansion occurs 
when the findings from the two data sets diverge and 
expand the insights on WLWH by addressing different 
or complementary aspects of the prenatal and postnatal 
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experience. Discordance occurs when survey and inter-
view results are inconsistent, contradictory or disagree 
with each other.39 The results of the MM joint display 
analysis will be presented on a theme- by- theme basis 
and represented with joint displays.39 71 A joint display 
is a table where the quantitative and qualitative results 
are presented side- by- side. In addition, the joint display 
contains overall interpretations across the data, so called 
metainferences.39 71 Thus, joint display construction will 
be used in both the analysis and in the presentation of 
the results.
rEsEArCH IntEgrIty to VAlIdIty ConCErns
Creswell and Plano Clark38 highlight three key consid-
erations to ensure validity in a convergent MM design. 
First, issues related to different sample sizes. In this study, 
the quantitative and qualitative data are collected for 
different purposes (quantitative generalisation vs qualita-
tive in- depth description)38 resulting in different sample 
sizes in the quantitative and qualitative phases. The 
two study phases are connected through the sampling 
strategy, that is, women included in the survey will also 
be asked to participate in the interviews. Thus, recruiting 
the same women in both phases of the study will enhance 
our ability to integrate the quantitative and qualitative 
results in an MM analysis.38 The second consideration is 
related to the challenge of merging a numeric database 
and text data.38 Preliminary overarching themes have 
been identified a priori, that is, stigma, depression, stress, 
social isolation and social support. The quantitative and 
qualitative data thereby address the same concepts, while 
still making room for new results and insights. The final 
consideration is related to the need to explain divergent 
or discordant results.38 Discordant results are not consid-
ered a limitation in this study due to the complementary 
nature of this research.40 Should discordance occur, we 
will re- examine the data, collect additional data if neces-
sary or use theory to explain the discordance.38
PAtIEnt And PublIC InVolVEMEnt
Patients and public were not involved in the development 
of the research question or the design of the study. Partic-
ipants will be asked to provide feedback on the dissemina-
tion and application of the results.
dIsCussIon
This paper describes the design of a convergent, longitu-
dinal MM study investigating psychosocial outcomes and 
experiences of WLWH in three Scandinavian countries 
during pregnancy and early motherhood. By publishing 
the protocol for this study, we make our methodolog-
ical choices explicit and transparent. Although the 
study procedures have been detailed, we recognise the 
importance of retaining flexibility to examine unex-
pected topics/events that arise. A MM approach allows 
this, specifically with the flexible qualitative methods and 
through integration of quantitative and qualitative data.36
This study illustrates several state- of- the art features for 
a MM study. Through advanced planning, the qualitative 
and quantitative data collection will be matched to ensure 
that information from each type of data can be considered 
together. The study will employ joint display analysis as a 
process to compel careful consideration of the two types 
of findings together, and the drawing of interpretations 
across the two types of findings, that is, making metainfer-
ences. The study design includes a plan for the examina-
tion of discordance, should it arise, using recommended 
procedures. In addition, the study has been planned 
with consideration of the most up- to- date thinking about 
research integrity threats when conducting a MM study.
The findings to come from this study have several poten-
tial implications. First, by drawing on the strengths of both 
quantitative and qualitative approaches in a MM design, 
this study will provide descriptive information of psychoso-
cial outcomes in WLWH across the pregnancy–postpartum 
trajectory, in addition to an understanding of the in- depth 
experiences of these women. Although, the lack of patient 
and community involvement during the development of 
the study could be a limitation. Second, understanding the 
experiences of WLWH in all its complexity is important 
because of the significance of maternal well- being on child 
outcomes and early intervention opportunities. Third, this 
study will include a nationwide sample of pregnant WLWH 
in Denmark and a sample of WLWH in both Finland and 
Sweden and follow them longitudinally. This will make it 
possible to capture changes in experiences over time and 
identify when in the pregnancy–postpartum trajectory 
interventions are most needed. Fourth, it is possible that 
some of the results will provide understanding of the posi-
tive interactions with healthcare professionals, thereby 
enhancing evidence- based practice. The results from this 
study can inform clinical practice in other Western coun-
tries that offer universal access to cART. Finally, this study 
can be utilised as a reference for the actual application of a 
convergent MM design in the field of maternal child health 
for WLWH.
tIMElInE
This is a 3- year study. Enrolment at the Danish sites was initi-
ated in December 2018 and at the Finnish sites in July 2019. 
Enrolment in Sweden is expected to commence in October 
2019. The enrolment of participants is estimated to take 18 
months, with an additional 8 months of collecting follow- up 
data in the survey study. The anticipated completion date is 
31 August 2021 (see figure 1).
EtHICs And dIssEMInAtIon
Approval from the Danish National Ethics Committee is 
not required as no biomedical intervention is performed. 
All participating women will be asked to provide volun-
tary written informed consent at the time of enrolment 
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and before any data collection. Data will be handled 
confidentially according the national regulations.
Study results will be disseminated through publications 
in peer- reviewed journals and at relevant scientific meet-
ings and conferences. Results will also be disseminated at 
relevant clinical departments, patient organisations and 
to the participating women.
ConClusIon
In the era of combination antiretroviral therapy, 
women living with HIV are still experiencing complex 
medical and psychosocial challenges during pregnancy 
and delivery. This multicentre longitudinal mixed 
methods study will provide a comprehensive knowl-
edge of the psychosocial experiences and emotional 
care needs of women living with HIV in Scandinavia. 
Understanding and responding to the experiences 
of pregnant and postpartum women living with HIV 
is important, so that goal- oriented interventions 
supporting these women can be developed.
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